Cite

HARVARD Citation

    Cirbus, K. et al. (2022). Rivaroxaban and apixaban for the treatment of suspected or confirmed heparin‐induced thrombocytopenia. Journal of clinical pharmacy and therapeutics. pp. 112-118. [Online]. 
  
Back to record